Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06588868 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

Study acronym: FIL_CTCL
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 2, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revised
    • Site details revised at 3 of 18 sites
    v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2025 to Feb 27, 2025
    • Site details revised at 18 of 18 sites
    v4
  3. Study sites: 16 to 18v3
  4. Study sites: 9 to 16v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is designed to describe the different approaches of systemic therapies for the treatment of Cutaneous T-cell Lymphoma in real world setting.
Trial Details
NCT Number NCT06588868
Lead Sponsor Fondazione Italiana Linfomi - ETS
Collaborators: Takeda
Conditions
(from sponsor)		 Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome
Related terms Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov